The European Commission announced on Wednesday (29 July) that batches of remdesivir, which can help recovery from Covid-19, will be made available to member states plus the UK from early August.
The commission this week signed a €63m contract with the US-based biopharmaceutical company Gilead to address "just immediate needs," after the US left Europe and most of the world without supplies.
Earlier this month, the Trump admi...
Back our independent journalism by becoming a supporting member
Already a member? Login hereElena is EUobserver's Managing Editor. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.
Elena is EUobserver's Managing Editor. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.